Vaccine-induced thrombotic thrombocytopaenia

Vaccine-induced thrombotic thrombocytopaenia — DVA SoP factors

Every factor in the Repatriation Medical Authority Statements of Principles for Vaccine-induced thrombotic thrombocytopaenia. DVA can only accept a claim for Vaccine-induced thrombotic thrombocytopaenia if at least one of these factors is met and connected to your service. Reasonable Hypothesis (RH) applies to operational service; Balance of Probabilities (BoP) applies to peacetime service.

Source: Repatriation Medical Authority Statements of Principles as held by the Veterans Health Centre. SoPs are amended and replaced regularly; always confirm the current instrument at rma.gov.au before relying on it.

Vaccine-induced thrombotic thrombocytopaenia

RH No. 33 of 2022 · BoP No. 34 of 20224 factors

Meaning of vaccine-induced thrombotic thrombocytopaenia: For the purposes of this Statement of Principles, vaccine-induced thrombotic thrombocytopaenia means a disorder of coagulation in which there is formation of blood clots in the vascular system in association with a low platelet count, in a person with no exposure to heparin within the previous 30 days.

Reasonable Hypothesis (RH) — Statement of Principles No. 33 of 2022

At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting vaccine- induced thrombotic thrombocytopaenia or death from vaccine-induced thrombotic thrombocytopaenia with the circumstances of a person's relevant service:

(1)
having received an adenovirus vector coronavirus disease 2019 (COVID-19) vaccine within the 100 days before the clinical onset of vaccine-induced thrombotic thrombocytopaenia; (a) Ad26.COV2.S (Janssen COVID-19 Vaccine); (b) ChAdOx1 nCoV-19 (Vaxevria, Oxford/Astra-Zeneca); (c) Gam-COVID-Vac (Sputnik V, Sputnik Light); and (d) AD5-nCOV (Convidecia);
Note: Examples of adenovirus vector COVID-19 vaccines include:.
(2)
inability to obtain appropriate clinical management for vaccine-induced thrombotic thrombocytopaenia;

Aggravation-only factors: the factors in subsection 8(2) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.

Balance of Probabilities (BoP) — Statement of Principles No. 34 of 2022

2 factors

At least one of the following factors must exist before it can be said that, on the balance of probabilities, vaccine-induced thrombotic thrombocytopaenia or death from vaccine-induced thrombotic thrombocytopaenia is connected with the circumstances of a person's relevant service:

(1)
having received an adenovirus vector coronavirus disease 2019 (COVID-19) vaccine within the 100 days before the clinical onset of vaccine-induced thrombotic thrombocytopaenia; (a) Ad26.COV2.S (Janssen COVID-19 Vaccine); (b) ChAdOx1 nCoV-19 (Vaxevria, Oxford/Astra-Zeneca); (c) Gam-COVID-Vac (Sputnik V, Sputnik Light); and (d) AD5-nCOV (Convidecia);
Note: Examples of adenovirus vector COVID-19 vaccines include:.
(2)
inability to obtain appropriate clinical management for vaccine-induced thrombotic thrombocytopaenia;

Accepted — what is it worth?

A Statement of Principles decides one thing only: whether DVA accepts liability for vaccine-induced thrombotic thrombocytopaenia. It says nothing about how much you are paid. Compensation is worked out separately, from impairment points under the GARP — so a condition can be accepted and still rate few points, or rate more than you expect once it is combined with everything else on your file.